BR9915589A - Use of unsubstituted azabicycloalkane derivatives - Google Patents

Use of unsubstituted azabicycloalkane derivatives

Info

Publication number
BR9915589A
BR9915589A BR9915589-3A BR9915589A BR9915589A BR 9915589 A BR9915589 A BR 9915589A BR 9915589 A BR9915589 A BR 9915589A BR 9915589 A BR9915589 A BR 9915589A
Authority
BR
Brazil
Prior art keywords
unsubstituted
derivatives
azabicycloalkane derivatives
azabicycloalkane
substituted
Prior art date
Application number
BR9915589-3A
Other languages
Portuguese (pt)
Inventor
Rainer Munschauer
Gerd Steiner
Gerhard Gross
Martin Traut
Liliane Unger
Hans-J Rgen Teschendorf
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9915589A publication Critical patent/BR9915589A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"USO DE DERIVADOS DE AZABICICLOALCANO N-SUBSTITUìDO" Esta invenção refere-se ao uso de derivados de 3-azabicicloalcano N-substituído da fórmula (I). em que B, R¹, R² e n têm os significados dados na descrição, para combater doenças de vício e outras doenças do sistema nervoso central."USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES" This invention relates to the use of N-substituted 3-azabicycloalkane derivatives of formula (I). where B, R¹, R² and n have the meanings given in the description, to combat diseases of addiction and other diseases of the central nervous system.

BR9915589-3A 1998-11-24 1999-11-12 Use of unsubstituted azabicycloalkane derivatives BR9915589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (en) 1998-11-24 1998-11-24 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
PCT/EP1999/008734 WO2000030639A1 (en) 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Publications (1)

Publication Number Publication Date
BR9915589A true BR9915589A (en) 2001-08-07

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915589-3A BR9915589A (en) 1998-11-24 1999-11-12 Use of unsubstituted azabicycloalkane derivatives

Country Status (21)

Country Link
EP (1) EP1133293A1 (en)
JP (1) JP2002530333A (en)
KR (1) KR20010080535A (en)
CN (1) CN1328455A (en)
AR (1) AR021502A1 (en)
AU (1) AU1775300A (en)
BG (1) BG105549A (en)
BR (1) BR9915589A (en)
CA (1) CA2352526A1 (en)
CZ (1) CZ20011796A3 (en)
DE (1) DE19854147A1 (en)
HK (1) HK1040933A1 (en)
HR (1) HRP20010472A2 (en)
HU (1) HUP0104416A3 (en)
IL (1) IL143181A0 (en)
NO (1) NO20012538L (en)
PL (1) PL348758A1 (en)
SK (1) SK7112001A3 (en)
TR (1) TR200101476T2 (en)
WO (1) WO2000030639A1 (en)
ZA (1) ZA200103976B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2589363A1 (en) 2004-12-13 2006-06-22 Eli Lilly And Company Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
CA2898045C (en) * 2013-01-15 2018-08-28 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2717288A (en) * 1987-11-12 1989-06-01 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
DE4427647A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use

Also Published As

Publication number Publication date
JP2002530333A (en) 2002-09-17
AU1775300A (en) 2000-06-13
SK7112001A3 (en) 2001-12-03
BG105549A (en) 2001-12-29
DE19854147A1 (en) 2000-05-25
NO20012538D0 (en) 2001-05-23
ZA200103976B (en) 2002-05-16
NO20012538L (en) 2001-07-04
TR200101476T2 (en) 2001-10-22
EP1133293A1 (en) 2001-09-19
CN1328455A (en) 2001-12-26
HUP0104416A3 (en) 2002-11-28
IL143181A0 (en) 2002-04-21
HK1040933A1 (en) 2002-06-28
WO2000030639A1 (en) 2000-06-02
PL348758A1 (en) 2002-06-03
CZ20011796A3 (en) 2002-05-15
HUP0104416A2 (en) 2002-04-29
KR20010080535A (en) 2001-08-22
HRP20010472A2 (en) 2003-04-30
AR021502A1 (en) 2002-07-24
CA2352526A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
BR9806752A (en) Phthalazinones.
BRPI0007487B8 (en) diphenyl-ureas substituted with w-carboxy-aryls as raf kinase inhibitors
DE69930269D1 (en) WATER-SOLUBLE PRODRUGS OF DISABLED PHENOLES
PT1233973E (en) ADENOSIN DERIVATIVES 5'-TIO-SUBSTITUTED NON-HETEROCYCLICS PARTIAL OR TOTAL AGENTS OF A1
TR200000782T2 (en) Resorcinol derivatives.
FI972580A0 (en) Preparations and procedures for reducing skin irritation
BR9910029A (en) Hydroxy indols, their application as phosphodiesterase 4 inhibitors and process for their preparation
BR0007527A (en) Phenylphenanthridines with IV-dependent inhibitory activity
BR9916307A (en) Quinoline derivatives
BR9811482A (en) 1- (n-phenylaminoalkyl) -piperazine derivatives substituted in position 2 of the phenolic ring
IT1285770B1 (en) CORTICOID COMPOUNDS
BR9910032A (en) Thienopyrimidines
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
BR0012169A (en) Dihydrobenzodiazepines and their use in the treatment of dyslipidemia
AR009809A1 (en) DERIVATIVES OF 10,13,15-TRIOXATRICICLO [9.2.1 (9.6)] - PENTADECANONE, PROCEDURES FOR ITS PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS
BR9812970A (en) Derivative of 3-substituted tetrahydropyridopyrimidinone, and, use of this
BR9915589A (en) Use of unsubstituted azabicycloalkane derivatives
BR9714049A (en) Imidazopyridazines
BR0109589A (en) Pyrane [2,3-c] imidazo [-1,2-a] pyridine derivatives for the treatment of gastrointestinal disorders
DE3765808D1 (en) HETEROCYCLIC TETRAHYDRO-3,4-DIAMINE-N-N'-PLATINUM COMPLEXES.
DE3783111T2 (en) FIVE-PIECE HETEROCYCLIC DERIVATIVES OF N'-SUBSTITUTED N, N'-DIACYLHYDRAZINES.
BR9713087A (en) Stabilized pharmaceutical composition, use and process to prepare it, and use of methanesulfonic acid or hydrochloric acid
BR9811631A (en) Derivative of carboxylic acid and its use
UY24915A1 (en) DERIVATIVES OF BENZOXAZINDIONA, APPLICATION OF THE SAME AND MEDICINES THAT CONTAIN THEM
DE3771597D1 (en) PYRIDAZINONE DERIVATIVES AND THEIR SALTS.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ABBOTT GMBH & CO KG. (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.